Metabolic syndrome has emerged as a worldwide health hazard to modern lifestyles, representing a range of metabolic disorders and a risk factor for cardiovascular disease. Although interesting and compelling evidence is being collected, it raises awareness of the need for further research in this area to continue to strengthen these associations and uncover the pathological processes that support them. Ultimately, it targets patients with metabolic syndrome as a group of individuals at increased risk of developing age-related eye disease and vision loss.

metabolic syndrome, retinopathy, changes in retinal vessels.

American Heart Association (AHA). About Metabolic Syndrome. Available at: https://www.heart.org/en/health-topics/metabolic-syndrome/about-metabolic-syndrome. Accessed June 25,2021

Sevil Karaman Erdur, Rukiye Aydin, Mustafa Ozsutcu, Oktay Olmuscelik,

Mustafa Eliacik, Goktug Demirci & Mehmet Selim Kocabora (2017): The Relationship between Metabolic Syndrome, Its Components, and Dry Eye: A Cross-Sectional Study, Current Eye Research, DOI :10.1080/02713683.2017.1280511

Wang SB, Mitchell P, Plant AJH, et al . Br J Ophthalmol 2016; 100 : 1041–1046 .​

Alberti KG, Zimmet P, Shaw J. Metabolic syndrome — a new world-wide defi nition . A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469 – 80

Jongh RT, Serne EH, RG IJ, et al . Impaired microvascular function in obesity: implications for obesity-associated microangiopathy, hypertension, and insulin resistance. Circulation 2004;109:2529 – 35.

Wong TY, Duncan BB, Golden SH, et al . Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk in Communities study. Invest Ophthalmol Vis Sci 2004;45:2949 – 54.

Kishore Kumar Godisela, Singareddy Sreenivasa Reddy, Chekkilla Uday Kumar, Natarajan Saravanan, Paduru Yadagiri Reddy, Monica M. Jablonski, Radha Ayyagari, Geereddy Bhanuprakash Reddy: Impact of obesity with impaired glucose tolerance on retinal degeneration in a rat model of metabolic syndrome/Molecular Vision 2017; 23:263-274 <http://www.molvis.org/molvis/v23/263> Received 3 December 2016 | Accepted 12 April 2017 | Published April 14, 2017

Bohlman H. Communicating the ocular and systemic complications of obesity to patients. Optometry 2005; 76:701-12. [PMID: 16361032] .

Cheung N, Wong TY. Obesity and eye diseases. Surv Ophthalmol 2007; 52:180-95. [PMID: 17355856] .

Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of

age-related macular degeneration. Am J Ophthalmol 2004;137:486-95. [PMID: 15013873] .

Matthias Huber, Peter Heiduschka, Focke Ziemssen, Juliane Bolbrinker and Reinhold Kreutz: Microangiopathy and visual deficits characterize the

retinopathy of a spontaneously hypertensive rat model with type 2 diabetes and metabolic syndrome/Hypertension Research (2011) 34, 103–112; doi:10.1038/hr.2010.168; published online 7 October 2010.

Cheung N, Wong TY. Diabetic retinopathy and systemic vascular complications. Prog Retin Eye Res 2008; 27 : 161–176.

Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, Matthews DR. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia 2001; 44 : 156–163.

Angelina Wong Shu Qing Chen Brayden D. Halvorson Jefferson C. Frisbee/Microvessel Density: Integrating Sex-Based Differences and Elevated Cardiovascular Risks in Metabolic Syndrome; J Vasc Res 2022;59:1–15